Characterization of the novel HLA-DRB1*14:207 allele by sequencing-based typing.


Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
07 2019
Historique:
received: 24 01 2019
accepted: 26 01 2019
pubmed: 2 4 2019
medline: 22 5 2020
entrez: 2 4 2019
Statut: ppublish

Résumé

HLA-DRB1*14:207 differs from HLA-DRB1*14:54:01:01 by one nucleotide substitution at codon 140 in exon 3.

Identifiants

pubmed: 30932368
doi: 10.1111/tan.13539
doi:

Substances chimiques

HLA-DRB1 Chains 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

85-86

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Auteurs

Vincent Elsermans (V)

CHRU de Lille, Institut d'Immunologie-HLA, Bd du Professeur Jules Leclercq, Lille, France.

Jonathan Visentin (J)

CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Place Amélie Raba Léon, Bordeaux, France.
UMR CNRS 5164 Immunoconcept, Université de Bordeaux, Bordeaux, France.

Isabelle Top (I)

CHRU de Lille, Institut d'Immunologie-HLA, Bd du Professeur Jules Leclercq, Lille, France.

Pauline Varlet (P)

CHRU de Lille, Institut d'Immunologie-HLA, Bd du Professeur Jules Leclercq, Lille, France.
INSERM U995 LIRIC, Université de Lille, Lille, France.

Myriam Labalette (M)

CHRU de Lille, Institut d'Immunologie-HLA, Bd du Professeur Jules Leclercq, Lille, France.
INSERM U995 LIRIC, Université de Lille, Lille, France.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH